Literature DB >> 12727638

Dendritic cells: controllers of the immune system and a new promise for immunotherapy.

Jacques Banchereau1, Sophie Paczesny, Patrick Blanco, Lynda Bennett, Virginia Pascual, Joseph Fay, A Karolina Palucka.   

Abstract

The immune system is controlled by dendritic cells (DCs). Just as lymphocytes comprise different subsets, DCs comprise several subsets that differentially control lymphocyte function. In humans, the myeloid pathway includes Langerhans cells (LCs) and interstitial DCs (intDCs). While both subsets produce IL-12, only intDCs make IL-10 and induce B cell differentiation. Another pathway includes plasmacytoid DCs, which promptly secrete large amounts of IFN-alpha/beta viral encounter. Thus, insights into in vivo DC functions are important to understand the launching and modulation of immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727638     DOI: 10.1111/j.1749-6632.2003.tb06047.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  50 in total

Review 1.  Endoscopic ultrasound-fine needle injection for oncological therapy.

Authors:  Jeremy Kaplan; Amaara Khalid; Natalie Cosgrove; Ayesha Soomro; Syed Mohsin Mazhar; Ali A Siddiqui
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

2.  Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection.

Authors:  Elina I Zuniga; Dorian B McGavern; Jose L Pruneda-Paz; Chao Teng; Michael B A Oldstone
Journal:  Nat Immunol       Date:  2004-11-07       Impact factor: 25.606

Review 3.  Targeting the dendritic cell: the key to immunotherapy in cancer?

Authors:  A Faith; C M Hawrylowicz
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

4.  Long-term productive human immunodeficiency virus infection of CD1a-sorted myeloid dendritic cells.

Authors:  Sergei Popov; Agnès-Laurence Chenine; Andreas Gruber; Pei-Lin Li; Ruth M Ruprecht
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection.

Authors:  Robert S Welner; Rosana Pelayo; Yoshinori Nagai; Karla P Garrett; Todd R Wuest; Daniel J Carr; Lisa A Borghesi; Michael A Farrar; Paul W Kincade
Journal:  Blood       Date:  2008-06-13       Impact factor: 22.113

6.  Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.

Authors:  James DeVoti; Lynda Hatam; Alexandra Lucs; Ali Afzal; Allan Abramson; Bettie Steinberg; Vincent Bonagura
Journal:  Mol Med       Date:  2014-08-28       Impact factor: 6.354

7.  Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma.

Authors:  Siqing Wang; Jing Yang; Jianfei Qian; Michele Wezeman; Larry W Kwak; Qing Yi
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

8.  Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow.

Authors:  Rosana Pelayo; Jun Hirose; Jiaxue Huang; Karla P Garrett; Alessio Delogu; Meinrad Busslinger; Paul W Kincade
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

9.  Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.

Authors:  Sumia Ali; Gwendalyn D King; James F Curtin; Marianela Candolfi; Weidong Xiong; Chunyan Liu; Mariana Puntel; Queng Cheng; Jesus Prieto; Antoni Ribas; Jerzy Kupiec-Weglinski; Nico van Rooijen; Hans Lassmann; Pedro R Lowenstein; Maria G Castro
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

Review 10.  Immunotherapy of advanced renal cell carcinoma: Current and future therapies.

Authors:  David Gill; Andrew W Hahn; Guru Sonpavde; Neeraj Agarwal
Journal:  Hum Vaccin Immunother       Date:  2016-08-05       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.